Cargando…

Interleukin 13 participates in terminal differentiation of esophageal squamous cell carcinoma cells

BACKGROUND: In China, esophageal squamous cell carcinoma (ESCC) accounts for more than 90% of all esophageal cancer cases. Interleukin 13 (IL-13) was widely reported to play a key role in tumor progression. Our previous study reported that IL-13 was a favorable predictive marker for the overall surv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jian, Wang, Wenjian, Wang, Ke, Ma, Guangwei, Shao, Jing, Fang, Weizhen, Zhou, Yiting, Lin, Jiatong, Guo, Yabin, Guan, Xinyuan, Duan, Chaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459211/ https://www.ncbi.nlm.nih.gov/pubmed/36092316 http://dx.doi.org/10.21037/jgo-22-559

Ejemplares similares

CD68 and interleukin 13, prospective immune markers for esophageal squamous cell carcinoma prognosis prediction
por: Li, Jian, et al.
Publicado: (2016)

HIF-1α Promotes the Metastasis of Esophageal Squamous Cell Carcinoma by Targeting SP1
por: Hu, Xueting, et al.
Publicado: (2020)

circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling
por: Hu, Xueting, et al.
Publicado: (2019)

The Role of Tumor Microenvironment in Invasion and Metastasis of Esophageal Squamous Cell Carcinoma
por: Zheng, Shuyue, et al.
Publicado: (2022)

Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma
por: Pan, Zihao, et al.
Publicado: (2019)

Correction for: Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma
por: Pan, Zihao, et al.
Publicado: (2020)

Interleukin-8 and Interleukin-6 Are Biomarkers of Poor Prognosis in Esophageal Squamous Cell Carcinoma
por: Pastrez, Paula Roberta Aguiar, et al.
Publicado: (2023)

Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China
por: Tang, Hong, et al.
Publicado: (2016)

Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma
por: Wang, Wenjian, et al.
Publicado: (2017)

Inhibiting Interleukin-19 Activity Ameliorates Esophageal Squamous Cell Carcinoma Progression
por: Hsing, Chung-Hsi, et al.
Publicado: (2013)

Interleukin-6 as a potential molecular target in esophageal squamous cell carcinoma
por: ZHAO, ZHI-FEI, et al.
Publicado: (2016)

Single‐Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma
por: Jia, Yongxu, et al.
Publicado: (2023)

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
por: Jiang, Zongdan, et al.
Publicado: (2021)

Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy
por: Shi, Qi, et al.
Publicado: (2018)

MicroRNA-212 facilitates the motility and invasiveness of esophageal squamous carcinoma cells
por: Chen, Zhi, et al.
Publicado: (2019)

Diagnostic Performance of Vascular Permeability and Texture Parameters for Evaluating the Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
por: Ji, Wenbing, et al.
Publicado: (2021)

Functional Polymorphisms in Interleukin-23 Receptor and Susceptibility to Esophageal Squamous Cell Carcinoma in Chinese Population
por: Ni, Bin, et al.
Publicado: (2014)

miR-671-5p Blocks The Progression Of Human Esophageal Squamous Cell Carcinoma By Suppressing FGFR2
por: Li, Xiaoyan, et al.
Publicado: (2019)

Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma
por: Guan, Xin, et al.
Publicado: (2020)

Esophageal Squamous Cell Carcinoma and Gastric Cardia Adenocarcinoma Shared Susceptibility Locus in PLCE1: A Meta-Analysis
por: Mai, Ruiqin, et al.
Publicado: (2013)

HOXC13 promotes proliferation of esophageal squamous cell carcinoma via repressing transcription of CASP3
por: Luo, Jing, et al.
Publicado: (2017)

Downregulation of HuR Inhibits the Progression of Esophageal Cancer through Interleukin-18
por: Xu, Xiaohui, et al.
Publicado: (2018)

Identification of a novel circ_0001946/miR‐1290/SOX6 ceRNA network in esophageal squamous cell cancer
por: Wang, Jianjun, et al.
Publicado: (2022)

DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma
por: Zhou, Y, et al.
Publicado: (2018)

Pathogenesis of allergen-induced eosinophilic esophagitis is independent of Interleukin (IL)-13
por: Niranjan, Rituraj, et al.
Publicado: (2013)

Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma
por: Lin, Zheng, et al.
Publicado: (2022)

The Integration Preference of Sleeping Beauty at Non-TA Site Is Related to the Transposon End Sequences
por: Zhou, Yiting, et al.
Publicado: (2021)

Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells
por: Mao, Yu, et al.
Publicado: (2019)

Identification and characterization of FGFR2(+) hematopoietic stem cell-derived fibrocytes as precursors of cancer-associated fibroblasts induced by esophageal squamous cell carcinoma
por: Qiu, Haibo, et al.
Publicado: (2022)

Esophageal mycobiome landscape and interkingdom interactions in esophageal squamous cell carcinoma
por: Rao, Wen-Qing, et al.
Publicado: (2023)

Butyrate and propionate restore interleukin 13‐compromised esophageal epithelial barrier function
por: Kleuskens, Mirelle T.A., et al.
Publicado: (2021)

Esophageal squamous cell carcinoma and prognosis in Taiwan
por: Cheng, Ya‐Fu, et al.
Publicado: (2018)

Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma
por: Wang, Lei, et al.
Publicado: (2022)

Immunotherapy for Esophageal Squamous Cell Carcinoma
por: Kojima, Takashi, et al.
Publicado: (2017)

AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression
por: Shi, Xuejiao, et al.
Publicado: (2016)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Interleukin‐33‐nuclear factor‐κB‐CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells
por: Yue, Ying, et al.
Publicado: (2020)

Long noncoding RNA SNHG12 induces proliferation, migration, epithelial–mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post‐transcriptional regulation of BMI1 and CTNNB1
por: Wu, Duoguang, et al.
Publicado: (2020)

DEK overexpression is predictive of poor prognosis in esophageal squamous cell carcinoma
por: Yi, Huochun, et al.
Publicado: (2019)

Interleukin 32 Promotes Foxp3(+) Treg Cell Development and CD8(+) T Cell Function in Human Esophageal Squamous Cell Carcinoma Microenvironment
por: Han, Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c7ava3p9vuc935q6bacrkc85uc